Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remazolam vs Etomidate-Propofol in Elderly Gastroenteroscopy
NCT05103696Completed
- Sponsor
- Peking University People's Hospital
- Start
- Oct 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam in Procedural sedation (PS) (2 arms), sponsored by Peking University People's Hospital. Primary endpoints: Induction time at Day 0, Recovery time at Day 0 and 2 more. Started Oct 2021; status: completed.
02
Drugs
remimazolam
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT05103696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05103696.